Isoform-specific inhibition of cyclophilins

Biochemistry

Volumn 48, Issue 26, 2009, Pages 6268-6277

  Daum, Sebastian ^a   Schumann, Michael ^a   Mathea, Sebastian ^a   Aumüller, Tobias ^a   Balsley, Molly A ^b   Constant, Stephanie L ^b   De Lacroix, Boris Féaux ^c   Kruska, Fabian ^c   Braun, Manfred ^c   Schiene Fischer, Cordelia ^a  

^a MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DEVELOPMENT; CELLULAR FUNCTION; CIS-TRANS; CIS-TRANS ISOMERIZATION; CYCLOPHILIN; CYCLOSPORIN; FLUORESCENCE ANISOTROPY; IN-VITRO; IN-VIVO; INFLAMMATORY DISEASE; ISOFORM; ISOMERASES; ISOTHERMAL TITRATION CALORIMETRY; PROLYL BONDS; SMALL-MOLECULE INHIBITORS; T CELLS;

AMINES; GROWTH KINETICS; ISOMERIZATION; PROTEIN FOLDING;

ENZYMES;

1 INDANYLKETONE; BENZOFURAN DERIVATIVE; CYCLOPHILIN A; CYCLOPHILIN B; ENZYME INHIBITOR; KETONE DERIVATIVE; PEPTIDYLPROLYL ISOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERMODYNAMICS;

ANIMALS; BENZOFURANS; BINDING, COMPETITIVE; BIOCATALYSIS; CATALYTIC DOMAIN; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS; CYCLOPHILIN A; CYCLOPHILINS; CYCLOSPORINE; ENZYME INHIBITORS; FLUORESCENCE POLARIZATION; HUMANS; INDANS; ISOENZYMES; KINETICS; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; PROTEIN BINDING; RECOMBINANT PROTEINS; THERMODYNAMICS;

HEPATITIS C VIRUS;

EID: 67650078271     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9007287     Document Type: Article

References (67)

1. Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., and Schmid, F. X. (1989) Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337, 476-478.
2. Takahashi, N., Hayano, T., and Suzuki, M. (1989) Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337, 473-475.
3. Liu, J., Farmer, J. D. Jr., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. (1991) Calcineurin is a common target of cyclophilin- cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815. (Pubitemid 121001714)
4. Fischer, G., and Aumu.ller, T. (2003) Regulation of peptide bond cis/ trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 148, 105-150.
5. Liu, J., Chen, C. M., and Walsh, C. T. (1991) Human and Escherichia coli cyclophilins: Sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue. Biochemistry 30, 2306-2310.
6. Fejzo, J., Etzkorn, F. A., Clubb, R. T., Shi, Y., Walsh, C. T., and Wagner, G. (1994) The mutant Escherichia coli F112W cyclophilin binds cyclosporin A in nearly identical conformation as human cyclophilin. Biochemistry 33, 5711-5720. (Pubitemid 24184572)
7. Wang, P., and Heitman, J. (2005) The cyclophilins. Genome Biol. 6, 226.
8. Lin, D. T., and Lechleiter, J. D. (2002) Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. J. Biol. Chem. 277, 31134-31141.
9. Leung, A. W., and Halestrap, A. P. (2008) Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim. Biophys. Acta 1777, 946-952.
10. Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., Gunn-Moore, F. J., Vonsattel, J. P., Arancio, O., Chen, J. X., and Yan, S.D. (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14, 1097-1105.
11. Horowitz, D. S., Lee, E. J., Mabon, S. A., and Misteli, T. (2002) A cyclophilin functions in pre-mRNA splicing. EMBO J. 21, 470-480.
12. Folk, P., Puta, F., and Skruzny, M. (2004) Transcriptional coregulator SNW/SKIP: The concealed tie of dissimilar pathways. Cell. Mol. Life Sci. 61, 629-640.
13. Yao, Q., Li, M., Yang, H., Chai, H., Fisher, W., and Chen, C. (2005) Roles of cyclophilins in cancers and other organ systems. World J. Surg. 29, 276-280.
14. Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., and Li, D. (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 64, 9018-9026. (Pubitemid 39665512)
15. Howard, B. A., Zheng, Z., Campa, M. J., Wang, M. Z., Sharma, A., Haura, E., Herndon, J. E.II, Fitzgerald, M. C., Bepler, G., and Patz, E. F.Jr. (2004) Translating biomarkers into clinical practice: Prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in nonsmall cell lung cancer. Lung Cancer 46, 313-323. (Pubitemid 39487306)
16. Li, Z., Zhao, X., Bai, S., Wang, Z., Chen, L., Wei, Y., and Huang, C. (2008) Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol. Cell. Proteomics 7, 1810-1823.
17. Zheng, J., Koblinski, J. E., Dutson, L. V., Feeney, Y. B., and Clevenger, C. V. (2008) Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res. 68, 7769-7778.
18. Fang, F., Flegler, A. J., Du, P., Lin, S., and Clevenger, C. V. (2009) Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am. J. Pathol. 174, 297-308.
19. Syed, F., Rycyzyn,M. A., Westgate, L., and Clevenger, C. V. (2003) A novel and functional interaction between cyclophilin A and prolactin receptor. Endocrine 20, 83-90. (Pubitemid 36515191)
20. Rycyzyn, M. A., Reilly, S. C., O'Malley, K., and Clevenger, C. V. (2000) Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol. Endocrinol. 14, 1175-1186.
21. Bukrinsky, M. I. (2002) Cyclophilins: Unexpected messengers in intercellular communications. Trends Immunol. 23, 323-325. (Pubitemid 34717897)
22. Arora, K., Gwinn,W. M., Bower, M. A., Watson, A., Okwumabua, I., MacDonald, H. R., Bukrinsky, M. I., and Constant, S. L. (2005) Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 175, 517-522. (Pubitemid 40884357)
23. Tegeder, I., Schumacher, A., John, S., Geiger, H., Geisslinger, G., Bang, H., and Brune, K. (1997) Elevated serum cyclophilin levels in patients with severe sepsis. J. Clin. Immunol. 17, 380-386.
24. Billich, A., Winkler, G., Aschauer, H., Rot, A., and Peichl, P. (1997) Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J. Exp. Med. 185, 975-980.
25. Sherry, B., Yarlett, N., Strupp, A., and Cerami, A. (1992) Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc. Natl. Acad. Sci. U.S.A. 89, 3511-3515.
26. Xu, Q., Leiva, M. C., Fischkoff, S. A., Handschumacher, R. E., and Lyttle, C. R. (1992) Leukocyte chemotactic activity of cyclophilin. J. Biol. Chem. 267, 11968-11971.
27. Allain, F., Vanpouille, C., Carpentier, M., Slomianny, M. C., Durieux, S., and Spik, G. (2002) Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 99, 2714-2719.
28. Yurchenko, V., O'Connor, M., Dai, W. W., Guo, H., Toole, B., Sherry, B., and Bukrinsky, M. (2001) CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun. 288, 786-788.
29. Yurchenko, V., Zybarth, G., O'Connor, M., Dai, W. W., Franchin, G., Hao, T., Guo, H., Hung,H. C., Toole, B., Gallay, P., Sherry, B., and Bukrinsky, M. (2002) Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 277, 22959-22965.
30. Watashi, K., Hijikata, M., Hosaka, M., Yamaji, M., and Shimotohno, K. (2003) Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 38, 1282-1288. (Pubitemid 37314838)
31. Nakagawa, M., Sakamoto,N., Enomoto, N., Tanabe, Y.,Kanazawa, N., Koyama, T., Kurosaki, M., Maekawa, S., Yamashiro, T., Chen, C. H., Itsui, Y., Kakinuma, S., and Watanabe, M. (2004) Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem. Biophys. Res. Commun. 313, 42-47.
32. Goto, K., Watashi, K., Murata, T., Hishiki, T., Hijikata, M., and Shimotohno, K. (2006) Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811. Biochem. Biophys. Res. Commun. 343, 879-884.
33. Ma, S., Boerner, J. E., TiongYip, C., Weidmann, B., Ryder, N. S., Cooreman, M. P., and Lin, K. (2006) NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with R interferon. Antimicrob. Agents Chemother. 50, 2976-2982.
34. Paeshuyse, J., Kaul, A., De Clercq, E., Rosenwirth, B., Dumont, J. M., Scalfaro, P., Bartenschlager, R., and Neyts, J. (2006) The nonimmunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 43, 761-770.
35. Flisiak, R., Horban, A., Gallay, P., Bobardt, M., Selvarajah, S., Wiercinska-Drapalo, A., Siwak, E., Cielniak, I., Higersberger, J., Kierkus, J., Aeschlimann, C., Grosgurin, P., Nicolas-Métral, V., Dumont, J. M., Porchet, H., Crabbë, R., and Scalfaro, P. (2008) The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis Cand human immunodeficiency virus. Hepatology 47, 817-826.
36. Crabbé, R., Vuagniaux, G., Dumont, J. M., Nicolas-Métral, V., Marfurt, J., and Novaroli, L. (2009) An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C. Expert Opin. Invest. Drugs 18, 211-220.
37. Watashi, K., Ishii,N., Hijikata,M., Inoue, D.,Murata, T.,Miyanari, Y., and Shimotohno,K. (2005)Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19, 111-122. (Pubitemid 40884662)
38. Yang, F., Robotham, J. M., Nelson, H. B., Irsigler, A., Kenworthy, R., and Tang, H. (2008) Cyclophilin A is an essential cofactor for hepatitis Cvirus infection and the principal mediator of cyclosporine resistance in vitro. J. Virol. 82, 5269-5278. (Pubitemid 351705235)
39. Lohmann, V.,Körner, F., Herian, U., and Bartenschlager, R. (1997) Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71, 8416-8428. (Pubitemid 27446422)
40. Bergsma, D. J., Eder, C., Gross, M., Kersten, H., Sylvester, D., Appelbaum, E., Cusimano, D., Livi, G. P., McLaughlin, M. M., Kasyan, K., Porter, T. G., Silverman, C., Dunnington, D., Hand, A., Prichett, W. P., Bossard, M. J., Brandt, M., and Levy, M. A. (1991) The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. J. Biol. Chem. 266, 23204-23214.
41. Nakagawa, M., Sakamoto, N., Tanabe, Y., Koyama, T., Itsui, Y., Takeda, Y., Chen, C. H., Kakinuma, S., Oooka, S., Maekawa, S., Enomoto, N., and Watanabe, M. (2005) Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins. Gastroenterology 129, 1031-1041. (Pubitemid 41242693)
42. Daum, S., Erdmann, F., Fischer,G., Féaux, B., Hessamian-Alinejad, A., Houben, S., Frank, W., and Braun, M. (2006) Aryl indanyl ketones: Efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1. Angew. Chem., Int. Ed. 45, 7454-7458. (Pubitemid 44786984)
43. Braun, M., Hessamian-Alinejad, A., de Lacroix, B. F., Alvarez, B. H., and Fischer, G. (2008) Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl cis/trans isomerase Pin1. Molecules 13, 995-1003.
44. Zhang, Y., Erdmann, F., Baumgrass, R., Schutkowski, M., and Fischer, G. (2005) Unexpected side chain effects at residue 8 of cyclosporin a derivatives allow photoswitching of immunosuppression. J. Biol. Chem. 280, 4842-4850.
45. Fanghänel, J., and Fischer, G. (2003) Thermodynamic characterization of the interaction of human cyclophilin 18 with cyclosporin A. Biophys. Chem. 100, 351-366.
46. Janowski, B., Wöllner, S., Schutkowski, M., and Fischer, G. (1997) A protease-free assay for peptidyl prolyl cis/trans isomerases using standard peptide substrates. Anal. Biochem. 252, 299-307.
47. Liu, Y., Jiang, J., Richardson, P. L., Reddy, R. D., Johnson, D. D., and Kati, W. M. (2006) A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A. Anal. Biochem. 356, 100-107.
48. Wang, Z. X. (1995) An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule. FEBS Lett. 360, 111-114.
49. Zhang, Y. L., and Zhang, Z. Y. (1998) Low-affinity binding determined by titration calorimetry using a high-affinity coupling ligand:A thermodynamic study of ligand binding to protein tyrosine phosphatase 1B. Anal. Biochem. 261, 139-148.
50. Kallen, J., Spitzfaden, C., Zurini, M. G., Wider, G., Widmer, H., Wüthrich, K., and Walkinshaw, M. D. (1991) Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Nature 353, 276-279.
51. Klebe, G., and Böhm, H. J. (1997) Energetic and entropic factors determining binding affinity in protein-ligand complexes. J. Recept. Signal Transduction Res. 17, 459-473.
52. Damsker, J. M., Bukrinsky, M. I., and Constant, S. L. (2007) Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A. J. Leukocyte Biol. 82, 613-618. (Pubitemid 47367153)
53. Wang, X. J., and Etzkorn, F. A. (2006) Peptidyl-prolyl isomerase inhibitors. Biopolymers 84, 125-146.
54. Hart, S. A., and Etzkorn, F. A. (1999) Cyclophilin Inhibition by a (Z)-Alkene cis-Proline Mimic. J. Org. Chem. 64, 2998-2999.
55. Wang, H. C., Kim, K., Bakhtiar, R., and Germanas, J. P. (2001) Structure-activity studies of ground- and transition-state analogue inhibitors of cyclophilin. J. Med. Chem. 44, 2593-2600.
56. Demange, L., Moutiez, M., and Dugave, C. (2002) Synthesis and evaluation of Glypsi(PO(2)R-N)Pro-containing pseudopeptides as novel inhibitors of the human cyclophilin hCyp-18. J. Med. Chem. 45, 3928-3933.
57. Fanghänel, J., and Fischer, G. (2004) Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. Front. Biosci. 9, 3453-3478.
58. Mikol, V., Kallen, J., and Walkinshaw, M. D. (1994) X-ray structure of a cyclophilin B/cyclosporin complex: Comparison with cyclophilin A and delineation of its calcineurin-binding domain. Proc. Natl. Acad. Sci. U.S.A. 91, 5183-5186.
59. Price, E. R., Zydowsky, L. D., Jin, M. J., Baker, C. H., McKeon, F. D., and Walsh, C. T. (1991) Human cyclophilin B: A second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc. Natl. Acad. Sci. U.S.A. 88, 1903-1907.
60. Neri, P., Gemmecker, G., Zydowsky, L.D., Walsh, C. T., and Fesik, S. W. (1991)NMRstudies of [U-13C]cyclosporin A bound to human cyclophilin B. FEBS Lett. 290, 195-199.
61. Olsson, T. S., Williams, M. A., Pitt, W. R., and Ladbury, J. E. (2008) The thermodynamics of protein-ligand interaction and solvation: Insights for ligand design. J. Mol. Biol. 384, 1002-1017.
62. Weber, P. C., Wendolowski, J. J., Pantoliano, M. W., and Salemme, F. R. (1992) Crystallographic and thermodynamic comparison of natural and synthetic ligands bound to streptavidin. J. Am. Chem. Soc. 114, 3197-3200.
63. Velazquez-Campoy, A., Kiso, Y., and Freire, E. (2001) The binding energetics of first and second generation HIV-1 protease inhibitors: Implications for drug design. Arch. Biochim. Biophys. 390, 169-175.
64. Wildemann, D., Erdmann, F., Alvarez, B. H., Stoller, G., Zhou, X. Z., Fanghänel, J., Schutkowski, M., Lu, K. P., and Fischer, G. (2006) Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J. Med. Chem. 49, 2147-2150.
65. Zhang, Y., Daum, S., Wildemann, D., Zhou, X. Z., Verdecia, M. A., Bowman, M. E., Lücke, C., Hunter, T., Lu, K. P., Fischer, G., and Noel, J. P. (2007) Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol. 2, 320-328.
66. Ke, H., Mayrose, D., Belshaw, P. J., Alberg, D. G., Schreiber, S. L., Chang, Z. Y., Etzkorn, F. A., Ho, S., and Walsh, C. T. (1994) Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4, 4-dimethylthreonine cyclosporin A. Structure 15, 33-44.
67. Fesik, S. W., Neri, P., Meadows, R., Olejniczak, E. T., and Gemmecker, G. (1992) A model of the cyclophilin/cyclosporin A (CSA) complex from NMR and X-ray data suggests that CSA binds as a transition-state analog. J. Am. Chem. Soc. 114, 3165-3166.